AlphaCentric Advisors LLC

Position in ABBV — AbbVie Inc.

CIK 1913464 SAN JUAN, PR

Position in ABBV

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$909,175

+$138,391 QoQ

Shares Held

3,613

+1.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.91%

of 13F equity value

Holder Rank

#2,636

of 4,153 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

AlphaCentric Advisors LLC holds $8,379,594 across 8 Drug Manufacturers - General names. ABBV ranks #3 (10.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	20,426	$2,580,620
2	AZN	Astrazeneca PLC	11,394	$2,160,530
3	ABBV	AbbVie Inc. This page	3,613	$909,175
4	AMGN	Amgen Inc	2,362	$855,327
5	BIIB	Biogen Inc.	3,891	$840,689
6	SNY	Sanofi	14,590	$622,409
7	JNJ	Johnson & Johnson	1,391	$353,272
8	LLY	ELI LILLY & Co	48	$57,572

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$909,175	3,613	+1.9%	Shares	Other	2026-07-24
2026-03-31	$770,784	3,544	+19.0%	Shares	Other	2026-05-07
2025-12-31	$680,671	2,979	-77.1%	Shares	Other	2026-02-12
2024-12-31	$2,313,298	13,018	+675.3%	Shares	Other	2025-01-31
2023-03-31	$267,582	1,679	-0.8%	Shares	Other	2023-05-12
2022-12-31	$273,605	1,693	+26.8%	Shares	Other	2023-02-13
2022-09-30	$179,170	1,335	+214.1%	Shares	Other	2022-11-08
2021-06-30	$47,872	425	0.0%	Shares	Other	2022-03-09
2021-03-31	$45,993	425	0.0%	Shares	Other	2022-03-09
2020-12-31	$45,538	425	0.0%	Shares	Other	2022-03-11
2020-09-30	$37,225	425	0.0%	Shares	Other	2022-03-11
2020-06-30	$41,726	425	—	Shares	Other	2022-03-11
No filing history on record for this holder in this stock.